This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Toxicology Letters | |
|---|---|
| Title | Toxicology Letters |
| Discipline | Toxicology |
| Abbreviation | Toxicol. Lett. |
| Publisher | Elsevier |
| Country | Netherlands |
| Frequency | Biweekly |
| History | 1977–present |
| Impact | 3.8 (example) |
Toxicology Letters is a peer-reviewed scientific journal focused on experimental and mechanistic studies in toxicology, publishing original research, reviews, and commentary. It serves as a venue for interdisciplinary work linking toxicology with pharmacology, pathology, molecular biology, and environmental health. The journal connects research communities across academic institutions, regulatory agencies, and industrial laboratories.
The journal was established in 1977 amid developments in regulatory science associated with the United States Environmental Protection Agency, the World Health Organization, and the rise of molecular toxicology in institutions such as the National Institutes of Health, the Karolinska Institute, and Imperial College London. Early editorial leadership drew contributors from centers including the University of California, Berkeley, the University of Chicago, and the University of Oxford, and interacted with advisory committees from the European Chemicals Agency and the United Nations Environment Programme. Over decades the journal reflected shifts associated with methodologies pioneered at the Max Planck Society, the Cold Spring Harbor Laboratory, and the Salk Institute, and tracked impacts of legislation such as the Toxic Substances Control Act and directives from the European Commission. Editorial boards included scientists affiliated with the National Institute for Occupational Safety and Health, the National Cancer Institute, Harvard University, and Johns Hopkins University School of Medicine.
Toxicology Letters publishes research on mechanisms of toxicity involving cellular models developed at the Scripps Research Institute, animal models used at the University of Toronto, and human biomonitoring studies coordinated by the Centers for Disease Control and Prevention. Topics intersect with pharmacokinetic modeling advanced at Massachusetts Institute of Technology, genomic toxicology informed by work at the Broad Institute, and computational approaches stemming from groups at Stanford University and the University of Cambridge. The journal features articles relevant to regulatory science at the Food and Drug Administration, ecotoxicology investigations associated with the Smithsonian Institution and the Natural History Museum, London, and occupational studies connected with the National Institute for Occupational Safety and Health. Reviews and commentaries often reference initiatives at the European Food Safety Authority, the Organisation for Economic Co-operation and Development, and research networks such as the Howard Hughes Medical Institute.
Published by Elsevier on a biweekly basis, the journal employs a peer-review process coordinated through editorial offices comparable to those at journals like Nature, Science, and The Lancet. Editors have historically been scholars from institutions such as University College London, Yale University, Columbia University, and the University of California, San Francisco. The editorial model integrates associate editors and advisory board members drawn from research centers including the National Institutes of Health, the Wellcome Trust, the Karolinska Institutet, and the University of Melbourne. Production and dissemination tie into infrastructures used by publishers including Springer Nature and Wiley-Blackwell, and indexing workflows intersect with databases maintained by Clarivate Analytics and Elsevier Research Intelligence.
The journal is abstracted and indexed in major bibliographic databases and citation services such as Chemical Abstracts Service, Scopus, and Web of Science. Metadata integration connects with catalogs at the Library of Congress, the British Library, and thematic repositories like the National Library of Medicine and PubMed Central. Citation tracking and metrics reporting involve platforms including Google Scholar, CrossRef, and Dimensions, while institutional repositories at places like MIT Libraries and Harvard Library facilitate access. Regulatory literature reviews citing the journal appear in assessments by the European Chemicals Agency, the United States Environmental Protection Agency, and international panels convened by the World Health Organization.
Over time the journal has influenced debates in areas debated at forums such as the Royal Society, the Academy of Medical Sciences (United Kingdom), and the National Academy of Sciences (United States). Its articles have been cited in risk assessments by the Food and Drug Administration, environmental impact reports by the United Nations Environment Programme, and policy white papers from the European Commission. The reception among researchers at the University of Michigan, University of Tokyo, Peking University, and McGill University has highlighted the journal’s role in advancing mechanistic toxicology and translating findings to regulatory contexts. Academic awards and recognition for authors include prizes administered by organizations such as the Society of Toxicology, the European Society of Toxicology, and the International Union of Toxicology.
The journal has published influential studies on mechanisms first elucidated by labs at Cold Spring Harbor Laboratory, pathway analyses related to work at the Broad Institute, and biomonitoring investigations coordinated with the Centers for Disease Control and Prevention. Notable contributions include method development building on techniques from the Max Planck Institute for Molecular Genetics, in vitro assays related to protocols from the National Institute of Environmental Health Sciences, and computational toxicology frameworks aligned with research at Carnegie Mellon University and ETH Zurich. Cross-disciplinary investigations have involved collaborations with researchers from Johns Hopkins Bloomberg School of Public Health, University of Sydney, Seoul National University, University of São Paulo, and the Weizmann Institute of Science, informing subsequent reviews in outlets such as Annual Review of Pharmacology and Toxicology and citations in monographs published by the Royal Society of Chemistry.
Category:Toxicology journals